A simple scoring system that can provide a quick search prognosis at the onset of an adult unrelated donor (URD) search could be a useful tool for transplant physicians. We aimed to determine whether patient human leukocyte Ag genotype frequency (GF) could be used as a surrogate measure of whether or not a potential
INTRODUCTION
Many malignant and non-malignant hematological diseases and inherited metabolic disorders can be cured by allogeneic hematopoietic stem cell transplantation. Only 30% of donor searches can identify a HLA-identical related donor, which is considered the preferred donor for transplantation. When a related matched donor cannot be identified, one option is to find a suitably HLA-matched unrelated donor (URD) from one of the many worldwide bone marrow donor registries. 1 HLA matching between the URD and patient is critical to improve overall survival and minimize the risk of transplantrelated mortality and GvHD. [2] [3] [4] [5] Currently, the consensus matching goal is a 10/10 allele match at HLA-A, -B, -C, -DRB1 and -DQB1. Although isolated DQB1 mismatching may not have a significant impact on overall survival, Pidala et al. noted an increase' in acute GvHD. 2, 6, 7 When a 10/10 URD is not available, a 9/10 URD is often considered an acceptable alternative. Matching at other loci (that is, DPB1 and DRB3/4/5) may also have a positive impact on survival in some circumstances and can be used as the secondary matching criteria. [6] [7] [8] [9] Other alternatives for transplantation are cord blood unit(s) (CBU) or a haploidentical-related donor. [10] [11] [12] The ability of a transplant center to efficiently identify a suitably matched URD can significantly affect search times, costs and, potentially, the success in providing a transplant to the patient in need.
Multiple previous studies have used individual HLA haplotype commonalities to predict the likelihood of finding a matched URD at the onset of the patient search. Pedron et al. used individual inferred HLA-A∼B∼DRB1 haplotypes to determine the probability of finding an HLA-matched URD. 13 Later studies correlated the probability of finding an URD with individual inferred HLA-A∼C∼B∼DRB1∼DQB1 haplotype commonalities, as well as the presence of rare alleles and uncommon C∼B or DRB1∼DQB1 associations. [14] [15] [16] [17] Most of these studies were performed on predominantly White (WH)-European populations, and the algorithms were not always straightforward or easy to use, as they required looking for specific haplotypes or alleles to classify patients. One prior study developed a scoring system that used National Marrow Donor Program's (NMDP) haplotype frequency data as a predictive measure; however, this was validated on a predominantly WH population and only measured the probability of finding a 10/10 URD. 18 We developed a simple scoring system that uses patient genotype frequency (GF) to predict whether a patient is likely to have a 10/10 and/or 9/10 URD from the NMDP Be The Match Registry (BTMR) HapLogic URD matching algorithm, which comprises about half of the 426 million URDs worldwide (The NMDP BTMR HapLogic search is comprised of donors from the following registries: Be The Match; Gift of Life Bone Marrow Foundation; the Germany, USA and Poland DKMS Donor Centers; Hadassah Bone Marrow Donor Registry (Israel); Europdonor Foundation (Netherlands); Knochenmarkspenderzentrale Dusseldorf (Germany); The Tobias Registry (Sweden); Norwegian Bone Marrow Donor Registry (Norway); and Welsh Bone Marrow Donor Registry (Wales)). This scoring system was devised for each ethnic group separately-WH, African American/Black (AFA), Asian/Pacific Islander (API) and Hispanic (HIS)-to account for the HLA diversity among groups. 19, 20 This scoring system could prove useful to transplant centers at the beginning of a search as a standardized method to understand the patient's likelihood of finding a 10/10 and/or 9/10 URD and, consequently, to promote the use of HLA expertize in challenging cases and devise an appropriate clinical treatment plan. 1 
MATERIALS AND METHODS
This study was approved by NMDP Institutional Review Board.
Patient GF estimation
Patient GF information was obtained using NMDP's publicly available haplostats.org application, which provides analysis of HLA typing using NMDP HLA haplotype frequencies by the ethnic group, 20,21 on newly entered BTMR patients from January to December 2013. Only patients with intermediate/high-resolution HLA-A, -B, -C, -DRB1 and -DQB1 typing were included. The A∼C∼B∼DRBX a ∼DRB1∼DQB1 haplotype frequency tables were used ( a DRBX = DRB3 or DRB4 or DRB5 or the lack of any of these three genes). GF was calculated using the patient's projected most likely individual haplotype frequencies within the patient's self-identified ethnic group, and assumes Hardy-Weinberg equilibrium. When the patient's ethnic group was unknown (UNK), GF data were derived from WH frequencies and analyzed separately. If the GF was undefined, due to the inability to describe the HLA typing as a pair of haplotypes, then that patient's GF was defaulted to the minimum GF observed across all populations.
Search productivity determination
Each search was run in the NMDP Traxis application, which is a web-based search management interface that transplant centers use to manage the search process and access URD and CBUs worldwide. The number of potential 9/10 and 10/10 URDs with an overall HapLogic predicted allele match 450% (that is, 450% likelihood that the patient and URD are allele matched at 10/10 or 9/10 alleles given the respective HLA typing resolution, reported ethnic group and population HLA frequency data) was recorded. 22 Patients were classified as having 'Good', 'Fair' or 'Poor' search productivity based upon the following (all counts have 450% HapLogic predicted match): 'Good': ⩾ 3 potential 10/10 and any number of 9/10 URDs; 'Fair': 1-2 potential 10/10 and any number of 9/10 URDs or a search with no 10/10 URDs, but ⩾ 3 potential 9/10 URDs; and 'Poor': no potential 10/10 and o3 potential 9/10 URDs. The number of 10/10 and 9/10 defined for each category was selected to account for some URD unavailability and less than full likelihood of being an HLA match, targeting at least one URD being available for donation.
Proportional odds model to classify search productivity and validation A proportional odds model 23 was fit to a random 50% of data used for training (n = 2410; Table 1 ) with search productivity ('Good', 'Fair' and 'Poor' defined using the HapLogic output), as the response and GF as a predictor. Model predictions were used to establish GF boundaries for each productivity category by the ethnic group. These GF classification boundaries were then applied to the remaining random 50% of data used for validation (n = 2411; Table 1 ) and the concordance for each productivity category was generated comparing predicted with the actual HapLogic URD search outcome by the ethnic group.
Clinical validation on URD search cohort
A subset of the validation cohort, representing only US patients, was followed for 1 year post preliminary search to identify the activation of URD/CBUs for HLA typing and transplant to look for differences in the progression by GF search prognosis. As an additional validation, the model was used to classify an independent data set of 'pseudo-patients' used in a previous study. 24, 25 In brief, this study estimated the URD match rate of four ethnic groups by creating pseudo-patients (that is, simulated patients) based on the typing of over 1300 randomly selected high-resolution-typed URDs on the BTMR (see cohort in Table 1 ). Searches were performed on these pseudo-patients and potential URDs were HLA-typed as necessary to determine whether a 10/10 or 9/10 matched URD from the BTMR could be identified. Our study used this data set of established cases and match outcomes (that is, 10/10 and 9/10) to validate the GF search prognosis strategy.
RESULTS
To establish a GF classification scheme, we determined GF boundaries by the ethnic group using the association of training data with outcomes of the HapLogic search (Table 2 ). For example, for the WH group, all GF ⩾ 2.2 × 10 − 7 are classified as 'Good' meaning these patients likely have ≥ 3 potential 10/10 URDs with a HapLogic predicted match of 450%. 'Fair' is defined as having a GF between 2.2 × 10 − 7 and 5.1 × 10 − 9 and 'Poor' corresponds to GF o 5.1 × 10
The GF boundaries, as defined from the training data, are plotted against the validation data's associated URD HapLogic prediction outcomes by the ethnic group (Figure 1) . The validation data model fit range in concordance from a minimum of 44% correct for HIS and AFA when classifying 'Poor' searches up to 94% correct for WH when classifying 'Good' searches. This range in model performance is due to different patterns of overlap in the 
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Unrelated donor search prognosis scoring K Wadsworth et al categories with respect to GF. For example, the WH searches have a pronounced clustering of 'Good' searches that are clearly separated from 'Fair' and 'Poor' searches. The rates of 'gross' misclassification, which we define as a misclassification event where the prediction is off by more than one adjacent category (that is, 'Poor' misclassified as 'Good' or vice versa), were quite low and calculated by the ethnic group to be UNK (1.55%), API (1.33%) and WH (0.12%), and lowest for HIS and AFA with 0%.
To assess whether 10/10 or 9/10 URDs were ultimately identified for the validation patients, search and transplant activity for the US patient subset of the validation cohort was evaluated after 1 year of preliminary search activation (Table 3) . Of the transplanted patients, 93% of the 'Good' searches used a 10/10 matched URD. The 'Fair' category showed increased use of CBU and 9/10 URD transplants compared with 'Good' searches. Fifty-two percent of 'Poor' searches that achieved transplant used a CBU and 25% transplanted with a 9/10 URD. Eleven of the 65 URD/CBU transplants that occurred for searches were classified as 'poor' transplanted with a 10/10 URD. However, the majority of these transplants (9/11) were from the UNK ethnic group and would have been classified as 'Good' if entered using the most likely predicted ethnic group (WH, AFA, API or HIS) based on HLA. Only 4% of the US patients who transplanted with an international URD not displayed on the HapLogic listing were unique in overall match level (that is, the only 10/10 or 9/10 for that patient). The overall search time (that is, initial URD activation to request for donation) varied from 38 days for a 'Good' search to 50 and 54 days for a 'Fair' and 'Poor' search, respectively.
Finally, when we applied our GF scheme to the pseudo-patient cohort, where the best available URD was known, 490% of pseudo-patients classified to the 'Good' category had a 10/10 URD, 20-35 and 2-8% across the ethnic groups had a 10/10 URD in the 'Fair' and 'Poor' categories, respectively (Figure 2 ). Applying the GF ranges to the 9/10 match rates outcome study resulted in a similar pattern as the 10/10 match rates, but with increased numbers of pseudo-patients in the 'Fair' and 'Poor' groups identifying a 9/10 URD (Figure 3) . Log(Genotype frequency) Productivity Figure 1 . Concordance of the validation data using GF boundaries established from the training data by the ethnic group. The vertical black lines denote the GF boundaries estimated from the training data, as listed in Table 2 . Each circle indicates a validation cohort search defined as that search productivity category (y axis) on the basis of the number of potential 10/10 and 9/10 donors then plotted according to its corresponding Log GF (x axis)-each category is separated for clarity. Note that the B and C cases on the left of the graphs indicate cases where no haplotype pairs could be identified and their GF values were set to the minimum value. Above each panel is the concordance (% correctly classified) by the ethnic group for each GF category on the validation data. A = 'Good'; B = 'Fair'; C = 'Poor' . AFA, African American/Black; API, Asian/Pacific Islander; HIS, Hispanic; UNK, unknown; WH, White. The percentage listed is the number out of the total number of searches in that GF category.
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DISCUSSION
Our study presents a simple scoring system to help provide a quick prognosis of URD search outcome that classifies a search into one of three search prognosis categories. Searches in the 'Good' category are likely to have a 10/10 URD, searches in the 'Fair' category may have a 10/10 URD and are likely to have a 9/10 URD, and those in the 'Poor' category are unlikely to identify a potential 10/10 URD and less likely to have a 9/10 URD. Importantly, depending on a center's donor source selection preferences in absence of a 10/10 URD (that is, 9/10 URD vs CBU vs haploidentical donor) and patient urgency for transplant, 'Fair' prognosis may be treated in similar manner to 'Poor' prognosis to quickly move to transplant when considered in conjunction with the review of the potential URD search results. Log(Genotype frequency) Figure 3 . Percentage of pseudo-patients that could identify at least a 9/10 donor by predicted GF search prognosis category and ethnic group. GF boundaries (vertical lines) are shown along with individual results (each dot represents one pseudo-patient case) of whether or not at least a 9/10 donor was found (slightly jittered to avoid over-plotting), plotted according to the Log (GF). Percentage of each GF category that identified at least a 9/10 donor by the ethnic group is displayed (that is, number of cases with GF search prognosis having at least a 9/10 donor/total number of cases assigned GF search prognosis). AFA, African American/Black; API, Asian/Pacific Islander; HIS, Hispanic; WH, White.
GF concordance for the WH group was the highest, which may reflect the large number of subjects evaluated for HLA population frequencies resulting in more comprehensive reference data. The GF ranges for the AFA, API and HIS ethnic groups were surprisingly similar to the WH boundary for a 'Poor' search, although the GF cutoff point between a 'Good' search and a 'Fair' search is roughly 10 times higher in the non-WH groups. This likely reflects the diversity of HLA in these non-WH populations as well as the fact that the ethnic group composition of URDs on the BTMR is reported to be 55% WH and 19% UNK (mostly European registries with primarily WH URD populations). The UNK GF ranges represent a heterogeneous group, most similar to the WH GF for a 'Good' search, likely because most of the patients classified as the UNK ethnic group are from predominantly WH European countries.
When the GF category and the search productivity category were not concordant, it was most often in a bordering category (498%). In addition, if not concordant, the general pattern across ethnic groups was for the GF search prognosis to be slightly pessimistic. For example, more often a patient was considered to have 'Fair' GF when indeed the search was more reflective of 'Good' search results. If used prospectively, this would result in an increase of escalation of cases for HLA consultation. In the WH group, 'Fair' was the least concordant category which may reflect how the 'Fair' category most closely correlates with predicting whether or not a 9/10 URD can be found. The mechanism of using the commonality of patient HLA haplotypes, as employed in this model, can fail to adequately project potential URD haplotypes when one allele located on an uncommon haplotype is exchanged for another allele (that is, single mismatch with the patient), which occurs as a frequent haplotype. This is less likely when both haplotypes are uncommon, as is frequently the case in the 'Poor' category.
Applying the GF ranges to the pseudo-patient data set 24 allowed us to validate these categories on a completely independent data set, with known search outcomes of having a 10/10 or 9/10 URD. This also removed the variability of transplant center activation, HLA typing practices and patient clinical factors, which can influence patient progression for a multitude of reasons. The results of this data fit nicely with the predicted GF ranges, with 494% of pseudo-patients in the 'Good' category having a 10/10 URD, 27% in the 'Fair' category and only 4% in the 'Poor' category. These data also show a decrement in the 9/10 URD match rate when moving from the 'Good' to 'Poor' categories. This includes a WH 9/10 (or better) match rate of 63% in the 'Poor' category, and albeit moderately likely, compares with an overall WH match rate of 93%. Although the GF corresponding to the reported patient ethnic group typically best reflects the patient search, there are times when another ethnic group may more accurately reflects the population represented on the actual URD list, which we demonstrated in the nine cases of UNK achieving a 10/10 URD despite being categorized as 'Poor' GF search prognosis. Adding to the complexity is the lack of standardized practices for collecting the ethnic group information on patients. How to best characterize HLA typing based on a genetic single ethnic group assignment or blend of haplotypes from multiple ethnic groups is an area of ongoing research. This could allow better classification of the UNK group or better search the strategies for patients, where a pair of haplotypes could not be identified in a single ethnic group haplotype frequency data set.
Previous studies have developed similar search prognosis strategies. However, some were more complicated, not publicly available, and developed for predominantly WH populations. [13] [14] [15] [16] [17] [18] The method developed in our study uses one indicator-a patient's GF-that can easily be calculated using the haplostats. org application. It can also be applied to any ethnic group (WH, AFA, API or HIS) or used when a patient's ethnic group is UNK.
If used prospectively, it is recommended that the UNK category GF only be used if the patient's ethnic information is not obtainable, given the heterogeneous population.
A current NMDP study is underway to evaluate the impact of early HLA specialist review and guidance for patients categorized as having 'Poor' search prognosis. Future study to understand how using this search prognosis schema can help support clinical decision-making at a transplant center is also of interest. In addition to its use as a prognostic indicator for prospective patient searches, in the absence of detailed information of the patient search, this surrogate measure could also be applied to retrospective studies evaluating the progression of patients through the URD search process by providing context of the patient's URD listing.
It is important to note that even though patients in the 'Poor' category are less likely to find a 10/10 URD, it does not mean one cannot be found or that there are none available. To define these categories, we only included those URDs with a HapLogic prediction of 450%. This may rule-out potential URDs with C-B or DRB1-DQB1 haplotype associations that have variability, but are still common associations (that is, DRB1*07:01 with either DQB1*02:02 or DQB1*03:03). In some cases, a 10/10 will be found, despite a low HapLogic prediction.
In addition, the BTMR only contains about half of the worldwide URD pool, so some URDs may be found in registries not evaluated using the HapLogic matching algorithm. However, only 4% of transplants in the US patient validation cohort utilized a source that did not have a comparably matched URD listed in the BMTR. Although the Bone Marrow Donors Worldwide application provides a nearly comprehensive listing of URDs, the current presentation does not include a predictive matching algorithm, thus requiring user analysis to determine likelihood of matching for patients for all but the most obvious cases. Assistance of an HLA specialist may lead to more efficient and more successful identification of a suitable URD in these cases.
Using these findings, we developed an online tool (http:// search-prognosis.b12x.org) that determines the search prognosis category using the patient HLA typing for the patient's selfidentified ethnic group and also for each of the four ethnic groups in the event that the patient's ethnic group is UNK. It is suggested to use the best prognosis category across the four ethnic groups. For instance, if a patient's self-identified ethnic group is reported to be WH, and the search prognosis category for WH is 'Poor', but for HIS is 'Good', it is more likely the overall search for this patient will be reflective of 'Good'.
Given the multiple sources of stem cells that are currently options for treatment, nearly all patients have some source for transplant available to them. Although not a replacement for an actual URD search, the results of this study show that the GF method may offer a quick way for transplant physicians to get an indication of the likely URD search outcome, suggest the need for engaging HLA expertize earlier in the search process, and guide early clinical consideration of alternative stem cell sources so as to not delay a life-saving therapy.
